Prognostic importance of thymidylate synthase expression in early breast cancer

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 1923-1931

  Pestalozzi, B C ^a   Peterson, H F ^a   Gelber, R D ^a   Goldhirsch, A ^a   Gusterson, B A ^a   Trihia, H ^a   Lindtner, J ^a   Cortes Funes H ^a   Simmoncini, E ^a   Byrne, M J ^a   Golouh, R ^a   Rudenstam, C M ^a   Castiglione Gertsch, M ^a   Allegra, C J ^a   Johnston, P G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; PREDNISONE; THYMIDYLATE SYNTHASE;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL;

EID: 0030986625     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.1923     Document Type: Article

References (31)

1. Grem JL: Fluorinated pyrimidines, in Chabner BA, Collins JM (eds): Cancer Chemotherapy, Principles and Practice. Philadelphia, PA, Lippincott, 1990, pp 180-224
2. Danenberg PV: Thymidylate synthase. A target enzyme in cancer chemotherapy. Biochim Biophys Acta 473:73-92, 1977
3. Pinedo HM, Peters GF: Fluorouracil: Biochemistry and pharmacology. J Clin Oncol 6:16753-16764, 1988
4. Washtein WL: Increased levels of thymidylate synthase in cells exposed to 5-fluorouracil. Mol Pharmacol 25:171-177, 1984
5. Berger SH, Chung-Her J, Johnson LF, et al: Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells. Mol Pharmacol 28:461-467, 1987
6. Clark JL, Berger SL, Mittelman A, et al: Thymidylate synthase gene amplification in a colon tumor resistant to fluoropyrimidine chemotherapy. Cancer Treat Rep 71:261-265, 1987
7. Johnston PG, Drake JC, Trepel J, et al: Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res 52:4306-4312, 1992
8. Swain SM, Lippman ME, Egan EF, et al: 5-Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer. J Clin Oncol 7:890-899, 1989
9. Chu E, Zinn S, Boarman D, et al: The interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Cancer Res 50:5834-5840, 1990
10. Chu E, Koeller DM, Johnston PG, et al: Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma. Mol Pharmacol 43:527-533, 1993
11. Johnston PG, Liang C-M, Henry S, et al: Production and characterization of monoclonal antibodies that localize human thymidylate synthase in the cytoplasm of human cells and tissue. Cancer Res 51:6668-6676, 1991
12. Horikoshi T, Danenberg KD, Stadlbauer THW, et al: Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res 52:108-116, 1992
13. National Institutes of Health Consensus Conference: Treatment of early-stage breast cancer. JAMA 265:391-395, 1991
14. The Ludwig Breast Cancer Study Group: Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle. N Engl J Med 319:677-683, 1988
15. The Ludwig Breast Cancer Study Group: Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320:491-496, 1989
16. Hsu SM, Raine L, Fanger H: Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 29:577-580, 1981
17. Kaplan EL, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc 53:457-481, 1958
18. Greenwood M: The Natural Duration of Cancer. Reports on Public Health and Medical Subjects. London, UK, His Majesty's Stationary Office, 33:1-26, 1926
19. Cox DR: Regression models and life tables. JR Stat Soc B 34:187-220, 1972
20. McGuire WL: Breast cancer prognostic factors: Evaluation guidelines. J Natl Cancer Inst 83:154-155, 1991
21. Osborne CK: Prognostic factors for breast cancer: Have they met their promise? J Clin Oncol 10:679-682, 1992
22. Gusterson BA, Gelber RD, Goldhirsch A, et al: Prognostic importance of C-erb B-2 expression in breast cancer. J Clin Oncol 10:1049-1056, 1992
23. Johnston PG, Fisher ER, Rockette HE, et al: The role of thymidylate synthase expression in prognosis and outcome to adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 12:2640-2648, 1994
24. Conrad AH, Ruddle FH: Regulation of thymidylate synthase activity in cultured mammalian cells. J Cell Sci 10:471-486, 1972
25. Navalgund LG, Rossann C, Muench AJ, et al: Cell cycle regulation of thymidylate synthase gene expression in cultured mouse fibroblasts. J Biol Chem 255:7386-7390, 1980
26. Pestalozzi BC, McGinn CJ, Kinsella TJ, et al: Increased thymidylate synthase protein levels are associated with proliferation but not cell cycle phase in asynchronous human cancer cells. Br J Cancer 71:1151-1157, 1995
27. Pestalozzi BC, McGinn CJ, Trepel J, et al: The role of thymidylate synthase and cell cycle in 5-fluorouracil sensitive and resistant cells. Proc Am Assoc Cancer Res 34:2473, 1993 (abstr)
28. Chu E, Voeller DM, Jones KL, et al: Identification of a thymidylate synthase ribonucleoprotein complex in human colon cancer cells. Mol Cell Biol 14:207-213, 1994
29. Chu E, Copur S, Jones KL, et al: Thymidylate synthase regulates the translation of P53 mRNA. Proc Am Assoc Cancer Res 36:3355, 1995 (abstr)
30. Alexander HR, Grem JL, Hamilton JM, et al: Thymidylate synthase protein expression is associated with response following neoadjuvant chemotherapy and resection for locally advanced gastric cancer. Cancer J 1:49-54, 1995
31. Johnston PG, Lenz HJ, Danenberg KD, et al: Thymidylate synthase protein and gene expression predicts for response to 5-fluorouracil leucovorin chemotherapy in patients with colorectal and gastric cancer. Cancer Res 55:1407-1412, 1995